Skip to content

Black Bird Biotech, Inc.

company.status.inactive

CIK 1409999fmd_1TV0NQCYEVZGCVDH0FEWPJPP4NManufacturing · Miscellaneous Manufacturing IndustriesTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2023, 54 periods

Latest annual · FY2022

Millions
Total revenues
0
Gross profit
0
Operating income
(1)
Net income
(2)

Latest quarter · Q3 FY2023

Millions
Total revenues
0
Gross profit
0
Operating income
(0)
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
+66.9%
Revenue, 5 yearsFY2017 to FY2022
n/m
Net income, 5 yearsFY2017 to FY2022
n/m

Black Bird Biotech, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$82,563$104,458-21%10-K 2023-03-21 · proof
Gross profit$33,012$19,587+68.5%10-K 2023-03-21 · proof
Operating income-$1.3 million-$1.5 million10-K 2023-03-21 · proof
Net income-$1.7 million-$1.8 million10-K 2023-03-21 · proof
Cash from operating activities-$1 million-$992,42810-K 2023-03-21 · proof
Total assets$218,508$774,204-71.8%10-K 2023-03-21 · proof
Total liabilities$868,678$103,994+735.3%10-K 2023-03-21 · proof
Cash and cash equivalents$44,448$499,766-91.1%10-K 2023-03-21 · proof
What was Black Bird Biotech, Inc.'s revenue in fiscal 2022?
Black Bird Biotech, Inc. reported revenue of $82,563 for fiscal 2022 (the year ended Dec 31, 2022), against $104,458 the year before (-21%). Source: the 10-K filed with the SEC on Mar 21, 2023. SEC
What was Black Bird Biotech, Inc.'s gross profit in fiscal 2022?
Black Bird Biotech, Inc. reported gross profit of $33,012 for fiscal 2022 (the year ended Dec 31, 2022), against $19,587 the year before (+68.5%). Source: the 10-K filed with the SEC on Mar 21, 2023. SEC
What was Black Bird Biotech, Inc.'s operating income in fiscal 2022?
Black Bird Biotech, Inc. reported operating income of -$1.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2023. SEC
What was Black Bird Biotech, Inc.'s net income in fiscal 2022?
Black Bird Biotech, Inc. reported net income of -$1.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$1.8 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2023. SEC
What was Black Bird Biotech, Inc.'s cash from operating activities in fiscal 2022?
Black Bird Biotech, Inc. reported cash from operating activities of -$1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$992,428 the year before. Source: the 10-K filed with the SEC on Mar 21, 2023. SEC
What are Black Bird Biotech, Inc.'s total assets?
As of Dec 31, 2022, Black Bird Biotech, Inc. reported total assets of $218,508, against $774,204 a year earlier (-71.8%). Source: the 10-K filed with the SEC on Mar 21, 2023. SEC
What are Black Bird Biotech, Inc.'s total liabilities?
As of Dec 31, 2022, Black Bird Biotech, Inc. reported total liabilities of $868,678, against $103,994 a year earlier (+735.3%). Source: the 10-K filed with the SEC on Mar 21, 2023. SEC
What are Black Bird Biotech, Inc.'s cash and cash equivalents?
As of Dec 31, 2022, Black Bird Biotech, Inc. reported cash and cash equivalents of $44,448, against $499,766 a year earlier (-91.1%). Source: the 10-K filed with the SEC on Mar 21, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1409999&period_type=annual&limit=5"

Information only, not investment advice.